HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Clinicians strive to meet needs of ‘underserved’ AYA population
-
- Thrombosis and anticoagulation: Highlights from the ASH Annual Meeting Stephan Moll, MD
- CDC: HAI declined in US hospitals
- Nursing school appoints dean
- AICR report reveals new angle on ‘mismatch repair’ in cancer John Sweetenham, MD, FRCP, FACP
- FDA grants orphan drug status to SL-701 for glioma treatment
- Tarextumab granted orphan drug designation for pancreatic, small cell lung cancers
- FDA grants priority review to Yondelis for treatment of advanced soft tissue sarcoma
- FDA approves 3-D breast imaging system
-
- FDA expands approval of Imbruvica to treat Waldenström's macroglobulinemia
- FDA grants breakthrough therapy designation to LentiGlobin for beta-thalassemia major
- FDA grants breakthrough therapy designation to MPDL3280A for PDL1–positive NSCLC
- FDA approves Ibrance for advanced breast cancer
- CMS model for oncology care encourages value over volume
- ABIM on Maintenance of Certification program: ‘We got it wrong’
- Abiraterone acetate plus prednisone improved OS in certain patients with prostate cancer
- Adherence to recommended colonoscopy surveillance intervals low
-
- Adjuvant chemotherapy may improve lung cancer outcomes in older patients
- Allogeneic HSCT prolonged RFS in NPM1-mutated AML
- Azacitidine, lenalidomide treatment appears safe for myelodysplastic syndrome, AML
- Barrett's esophagus patients preferred endoscopic intervention for esophageal adenocarcinoma
- Bevacizumab-induced hypertension associated with improved OS, PFS in glioblastoma
- Biomarkers predicted severity of GVHD after allogeneic HSCT
- Breast cancer stage at diagnosis, survival vary by race, ethnicity
- Brentuximab vedotin may extend disease control in relapsed, refractory Hodgkin's lymphoma
-
- Children of melanoma survivors do not adequately protect themselves from sun
- Circulating cell-free DNA sheds light on genetic diversity of Hodgkin's lymphoma
- Circulating neutrophil, monocyte, lymphocyte counts predict survival in HPV-positive oropharyngeal cancer
- CMS finalizes decision to cover lung cancer screening
- Expansion of genetic testing feasible for familial CRC
- High-dose selenium supplementation may increase risk for prostate cancer mortality
- Incident cancer linked to increased short-term stroke risk
- Large retroperitoneal lymphadenopathy predicted VTE risk in disseminated germ cell tumors
-
- Liberal blood transfusion did not increase mortality risk in patients with heart disease
- Long-term hormonal contraceptive use linked to increased brain tumor risk
- Model improves prediction of breast cancer risk after benign biopsy
- Neoadjuvant HER-2–targeted breast cancer therapies less effective in patients with PIK3CA mutations
- New model accurately predicted HCC recurrence after transplantation
- Novel gene mutations associated with CRC in black patients identified
- Palliative care benefited patients with advanced pancreatic cancer
- Pioglitazone, rosiglitazone did not increase bladder cancer risk in patients with type 2 diabetes
-
- Platelet transfusions associated with increased risk for death in HIT, TTP
- Pretreatment affects outcomes in patients with metastatic melanoma
- Prevention of HBV reactivation improved with entecavir in patients with DLBCL
- Rotating night shifts raised mortality risk for US female nurses
- Somatostatin receptors serve as viable markers in bronchopulmonary neuroendocrine neoplasms
- Clinician experience linked to survival after radiation therapy for head and neck cancers
- Surgery plus radiation improves outcomes in oral cavity, maxillary sinus cancers
- Targeted fusion-guided biopsy improved detection of high-risk prostate cancers
-
- TH-302 regimen improved PFS, response in pancreatic cancer
- Trend against combined-modality therapy for early-stage Hodgkin's lymphoma may impact survival
- Type 2 diabetes moderately increased risk for colorectal cancer
- Hospice care reduced end-of-life costs, hospitalizations for Medicare beneficiaries
- Childrens hospital appoints leukemia director
- Meridian Cancer Care appoints medical director
- NIH recruits three Lasker scholars
- Oncologist named chairman of Florida Board of Medicine
-
- Physician-researcher joins City of Hope
- Optune plus temozolomide extended survival in glioblastoma